Bristol-Myers Squibb Co (XSWX:BMY) Accounts Payable & Accrued Expense : CHF6,032 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Bristol-Myers Squibb Co Accounts Payable & Accrued Expense?

Bristol-Myers Squibb Co's quarterly accounts payable & accrued expense increased from Sep. 2023 (CHF5,219 Mil) to Dec. 2023 (CHF5,355 Mil) and increased from Dec. 2023 (CHF5,355 Mil) to Mar. 2024 (CHF6,032 Mil).

Bristol-Myers Squibb Co's annual accounts payable & accrued expense increased from Dec. 2021 (CHF4,851 Mil) to Dec. 2022 (CHF5,123 Mil) and increased from Dec. 2022 (CHF5,123 Mil) to Dec. 2023 (CHF5,355 Mil).

Bristol-Myers Squibb Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Bristol-Myers Squibb Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Accounts Payable & Accrued Expense Chart

Bristol-Myers Squibb Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

5,384.65

4,373.59

4,850.91

5,122.87

5,354.84

Bristol-Myers Squibb Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															5,478.04	5,483.44	5,219.48	5,354.84	6,031.82

Bristol-Myers Squibb Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Bristol-Myers Squibb Co (XSWX:BMY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (XSWX:BMY) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

BMYMP.PFD:USA BMY:USA BMY:Peru BMY:Mexico 1BMY:Italy BRMd:UK 0R1F:UK BRM:Germany BMYB34:Brazil BMYS:Austria BMY:Argentina

Address

430 East 29th Street, 14th Floor, New York, NY, USA, 10016

Website

https://www.bms.com

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.